Arthur Lee Rosenthal

Arthur Lee Rosenthal is a declared insider of Profound Medical Corp. (formerly Mira IV Acquisition Corp.), with filings sourced from SEDI. Over a trading history stretching from 14 June 2018 to 2 June 2022, the count stands at 6 filings.

Purchases make up the whole of the open-market record (5 purchases, €140k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2022: 4 purchases and no sales on the market.

The median purchase comes to €20k. No cluster: in 5 purchases, no other insider of the company bought within 30 days.

Most recently, on 2 June 2022, the filings show an open-market purchase worth €45k in Profound Medical Corp. (formerly Mira IV Acquisition Corp.). Between a trade and the moment it shows up on SEDI, the median delay is 1 day. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.